Analyst Reco. Elutia Inc.

Equities

ELUT

US05479K1060

Delayed Nasdaq Other stock markets 03:45:01 2024-05-28 pm EDT			5-day change	1st Jan Change
3.26 ^USD	+0.31%		-3.55%	+50.93%

May. 09	Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Earnings Flash (ELUT) ELUTIA Posts Q1 Revenue $6.7M, vs. Street Est of $6.1M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cantor Fitzgerald Cuts Elutia's Price Target to $6 From $8, Keeps Overweight Rating	Nov. 14	MT
Lake Street Initiates Elutia at Buy Rating With $3 Price Target	23-09-28	MT
Equity Futures Trend Higher as Investors Expect No Rate Hike From Fed	23-09-19	MT
Cantor Fitzgerald Trims Price Target on Aziyo Biologics to $10 From $12, Maintains Overweight Rating	23-05-12	MT
Turist Securities Adjusts Aziyo Biologics Price Target to $10 From $8, Maintains Buy Rating	22-11-16	MT
Piper Sandler Adjusts Price Target on Aziyo Biologics to $10.50 From $9, Maintains Overweight Rating	22-11-15	MT
Cowen Adjusts Aziyo Biologics' Price Target to $13 From $15, Keeps Outperform Rating	22-03-04	MT
Piper Sandler Adjusts Aziyo Biologics' Price Target to $9 From $11, Reiterates Overweight Rating	22-03-04	MT
Piper Sandler Adjusts Aziyo Biologics' Price Target to $11 From $14, Reiterates Overweight Rating	21-11-10	MT
AZIYO BIOLOGICS : Piper Sandler Adjusts Aziyo Biologics PT to $14 From $20, Maintains Overweight Rating	21-06-07	MT
AZIYO BIOLOGICS : Cantor Fitzgerald Starts Aziyo Biologics at Overweight With $20 Price Target	20-11-02	MT
AZIYO BIOLOGICS : Cowen Starts Aziyo Biologics at Outperform With $20 Price Target	20-11-02	MT
AZIYO BIOLOGICS : Truist Securities Starts Aziyo Biologics at Buy With $20 Price Target	20-11-02	MT
AZIYO BIOLOGICS : Piper Sandler Starts Aziyo Biologics at Overweight With $20 Price Target	20-11-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer